Antiviral mode of action of lactobacillus plantarum yml009 on influenza virus h1n1

Bangladesh Journal of Pharmacology

Volumn 10, Issue 2, 2015, Pages 475-482

  Rather, Irfan A ^a   Choi, Kwang Ho ^a   Bajpai, Vivek K ^a   Park, Yong Ha ^a  

^a Department of Applied Microbiology and Biotechnology ^*  (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84941138915     PISSN: 1991007X     EISSN: 19910088     Source Type: Journal    
DOI: 10.3329/bjp.v10i2.23068     Document Type: Article

References (24)

1. Beigel J, Bray M. Current and future antiviral therapy of severe seasonal and avian influenza. Antiviral Res. 2008; 78: 91-102.
2. Corr SC, Gahan CG, Hill C. Impact of selected Lactobacillus and Bifidobacterium species on Listeria monocytogenes infection and the mucosal immune response. FEMS Immunol Med Microbiol. 2007; 50: 380-88.
3. Drouault S, Corthier G. Health effects of lactic acid bacteria ingested in fermented milk. Vet Res. 2001; 32: 101-17.
4. Dunne C, O’Mahony L, Murphy L, Thornton G, Morrissey D, O'Halloran S, Feeney M, Flynn S, Fitzgerald G, Daly C, Kiely B, O'Sullivan GC, Shanahan F, Collins JK. In vitro selection criteria for probiotic bacteria of human origin: Correlation with in vivo findings. Am J Clin Nutr. 2001; 73: S386-92.
5. EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP). Guidance on the assessment of bacterial susceptibility to anti-microbials of human and veterinary importance. EFSA J. 2012; 10: 2740.
6. ES ISO. Milk and milk products: Determination of the minimal inhibitory concentration (MIC) of antibiotics applicable to bifidobacteria and non-enterococal lactic acid bacteria. ESA. 2012; 10932.
7. Fujiwara D, Inoue S, Wakabayashi H, Fujii T. The anti-allergic effects of lactic acid bacteria are strain dependent and mediated by effects on both Th1/Th2 cytokine expression and balance. Int Arch Allergy Immunol. 2004; 135: 205-15.
8. Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med. 2009; 361: 1945–52.
9. Hanniffy S, Wiedermann U, Repa A, Mercenier A, Daniel C, Fioramonti J, Tlaskolova H, Kozakova H, Israelsen H, Madsen S, Vrang A, Hols P, Delcour J, Bron P, Kleerebezem M, Wells J. Potential and opportunities for use of recombinant lactic acid bacteria in human health. Adv Appl Microbiol. 2004; 56: 1-64.
10. Ishida Y, Nakamura F, Kanzato H, Sawada D, Hirata H, Nishimura A, Kajimoto O, Fujiwara S. Clinical effects of Lactobacillus acidophilus strain L-92 on perennial allergic rhinitis: A double-blind, placebo-controlled study. J Dairy Sci. 2005; 88: 527-33.
11. Kobayashi Y, Toyama K, Terashima T. Biological characteris-tics of Lactobacillus. II. Tolerance of a multiple antibiotic resistant strain, Lactobacillus casei PSR 3002, to artificial digestive fluids. Japanese J Bacteriol. 1974; 27: 691-97.
12. Long JK, Mossad SB, Goldman MP. Antiviral agents for treating influenza. Cleve Clin J Med. 2000; 67: 92-95.
13. Nagai T, Makino S, Ikegami S, Itoh H, Yamada H. Effects of oral administration of yogurt fermented with Lactobacillus delbrueckii ssp. Bulgaricus OLL1073R-1 and its exopolysa-ccharides against influenza virus infection in mice. Int Immunopharmacol. 2011; 11: 2246-50.
14. Nagao F, Nakayama M, Muto T, Okumura K. Effects of a fermented milk drink containing Lactobacillus casei strain Shirota on the immune system in healthy human subjects. Biosci Biotechnol Biochem. 2000; 64: 2706-08.
15. Nomura M, Kobayashi M, Narita T, Kimoto-Nira H, Okamoto T. Phenotypic and molecular characterization of Lactococcus lactis from milk and plants. J Appl Microbiol. 2006; 101: 396-405.
16. Oh S, Kim SH, Worobo RW. Characterization and purification of a bacteriocin produced by a potential probiotic culture, Lactobacillus acidophilus 30SC. J Dairy Sci. 2000; 83: 2747-54.
17. Park MK, NGO V, Kwon YM, Lee YT, Yoo S, et al. Lactobacillus plantarum DK119 as a probiotic confers protection against influenza virus by modulating innate immunity. PLoS ONE. 2013; 8: e75368.
18. Parvez S, Malik KA, Ah Kang S, Kim HY. Probiotics and their fermented food products are beneficial for health. J Appl Microbiol. 2006; 100: 1171-85.
19. Petros AM, Konstantinos CM, Dimitris P, Silvia C, Jana F, Mette D C, Effie T. Functional properties of novel protective lactic acid bacteria and application in raw chicken meat against Listeria monocytogenes and Salmonella enteritidis. J Food Microbiol. 2009; 130: 219-26.
20. Rather IA, Seo BJ, Rejish VJK, Choi UH, Choi KH, Lim JH, Park YH. Isolation and characterization of a proteinaceous antifungal compound from Lactobacillus plantarum YML007 and its application as a food preservative. Lett Appl Microbiol. 2013; 57: 69-76.
21. Reed LJ, Muench H. A simple method of estimating fifty percent endpoints. Am J Hyg. 1938; 27: 493-97.
22. Seo BJ, Rather IA, Kumar VJR, Choi UH, Moon MR, Lim JH, Park YH. Evaluation of Leuconostoc mesenteroides YML003 as a probiotic against low-pathogenic avian influenza (H9N2) virus in chickens. J Appl Microbiol. 2012; 113: 163-71.
23. Thompson WW, Shay DK, Weintraub E, Brammer L, Bridges CB, Cox NJ, Fukuda K. Influenza-associated hospitalizations in the United States. JAMA. 2004; 292: 1333-40.
24. Youn HN, Lee DH, Lee YN, Park JK, Yuk SS, et al. Intranasal administration of live Lactobacillus species facilitates protection against influenza virus infection in mice. Antiviral Res. 2012; 93: 138-43.